Avid Bioservices Inc (CDMO)

[RRdog]

Anything is possible, but, I think more one step at a time as the research comes forward would be more likely for Roche and much better for PPHM. A cash infusion for viral with a BP with milestones and royalties would change the whole aura of PPHM.

I don't think PPHM would grant them a right of first refusal in the cancer area either.

As aggressive as Roche is I think a "right of first look" at the data would be sufficient if Roche wanted to launch a preemptive strike on other assets when the time was ripe.

In addition, I think Cotara is a separate deal as well from the main body of Bavi cancer.

Regards,
RRdog